4basebio (4BB) Competitors GBX 800 -32.50 (-3.90%) As of 08:35 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock 4BB vs. SLN, HZD, PRTC, VRP, AVCT, FARN, ARIX, CIR, BVXP, and TILSShould you be buying 4basebio stock or one of its competitors? The main competitors of 4basebio include Silence Therapeutics (SLN), Horizon Discovery Group plc (HZD.L) (HZD), PureTech Health (PRTC), Verona Pharma plc (VRP.L) (VRP), Avacta Group (AVCT), Faron Pharmaceuticals Oy (FARN), Arix Bioscience (ARIX), Circassia Group (CIR), Bioventix (BVXP), and Tiziana Life Sciences (TILS). These companies are all part of the "biotechnology" industry. 4basebio vs. Its Competitors Silence Therapeutics Horizon Discovery Group plc (HZD.L) PureTech Health Verona Pharma plc (VRP.L) Avacta Group Faron Pharmaceuticals Oy Arix Bioscience Circassia Group Bioventix Tiziana Life Sciences Silence Therapeutics (LON:SLN) and 4basebio (LON:4BB) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, media sentiment, analyst recommendations and institutional ownership. Do institutionals and insiders hold more shares of SLN or 4BB? 1.0% of 4basebio shares are owned by institutional investors. 12.0% of 4basebio shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts rate SLN or 4BB? 4basebio has a consensus target price of GBX 1,600, suggesting a potential upside of 100.00%. Given 4basebio's stronger consensus rating and higher possible upside, analysts plainly believe 4basebio is more favorable than Silence Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Silence Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.004basebio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is SLN or 4BB more profitable? Silence Therapeutics' return on equity of 0.00% beat 4basebio's return on equity.Company Net Margins Return on Equity Return on Assets Silence TherapeuticsN/A N/A N/A 4basebio N/A -231.29%-54.30% Which has preferable valuation & earnings, SLN or 4BB? Silence Therapeutics has higher revenue and earnings than 4basebio. 4basebio is trading at a lower price-to-earnings ratio than Silence Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilence Therapeutics£11.35M0.00N/A-£48.60N/A4basebio£933K132.78-£9.84M-£0.94-851.06 Does the media refer more to SLN or 4BB? In the previous week, 4basebio had 1 more articles in the media than Silence Therapeutics. MarketBeat recorded 1 mentions for 4basebio and 0 mentions for Silence Therapeutics. 4basebio's average media sentiment score of 0.75 beat Silence Therapeutics' score of 0.00 indicating that 4basebio is being referred to more favorably in the news media. Company Overall Sentiment Silence Therapeutics Neutral 4basebio Positive Summary4basebio beats Silence Therapeutics on 8 of the 12 factors compared between the two stocks. Get 4basebio News Delivered to You Automatically Sign up to receive the latest news and ratings for 4BB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart 4BB vs. The Competition Export to ExcelMetric4basebioBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£123.88M£232.19M£5.78B£2.56BDividend YieldN/A3.78%5.74%5.31%P/E Ratio-851.0634.5677.085,413.58Price / Sales132.784,719.68507.1097,414.29Price / Cash16.0813.1937.1727.93Price / Book-19.51133.8013.699.12Net Income-£9.84M-£90.99M£3.29B£5.89B7 Day Performance-5.88%0.25%3.23%0.67%1 Month Performance-5.97%19.25%8.37%3.25%1 Year Performance-42.86%777.13%82.31%190.10% 4basebio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)4BB4basebio1.3728 of 5 starsGBX 800-3.9%GBX 1,600+100.0%-39.9%£123.88M£933K-851.06101SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumeHZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416PRTCPureTech Health2.3625 of 5 starsGBX 113.20-0.9%GBX 455+301.9%-26.0%£273.59M£6.17M665.88300News CoverageGap UpVRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpAVCTAvacta GroupN/AGBX 55.80+1.5%N/A-17.3%£224.19M£113K-363.75120FARNFaron Pharmaceuticals OyN/AGBX 189.30+2.3%N/A-17.4%£211.93MN/A-701.1134Gap UpARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919CIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap DownBVXPBioventixN/AGBX 2,448+0.9%N/A-33.2%£127.91M£13.66M1,652.7112TILSTiziana Life SciencesN/AN/AN/AN/A£113.85M-£3.60M-3.5911Positive News Related Companies and Tools Related Companies Silence Therapeutics Competitors Horizon Discovery Group plc (HZD.L) Competitors PureTech Health Competitors Verona Pharma plc (VRP.L) Competitors Avacta Group Competitors Faron Pharmaceuticals Oy Competitors Arix Bioscience Competitors Circassia Group Competitors Bioventix Competitors Tiziana Life Sciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:4BB) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4basebio PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share 4basebio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
